ACTRN12622000499785
Recruiting
未知
Preventing adverse events during paediatric cancer treatment: A multi-site hybrid randomised controlled trial of catheter lock solutions (The CLOCK trial)
niversity of Queensland0 sites720 target enrollmentMarch 29, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Paediatric Cancer
- Sponsor
- niversity of Queensland
- Enrollment
- 720
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children (\<18 years) with an oncological or malignant haematological condition who have a CVAD in situ (including peripherally inserted central catheters \[PICCs], tunnelled (cuffed or non\-cuffed) \[e.g. Hickman®; Becton Dickinson, US] and totally implanted \[e.g. PORT\-A\-CATH®; Smith Medical, US] will be eligible for inclusion. ; Children (\<18 years) with an oncological or malignant haematological condition who have a CVAD in situ (including peripherally inserted central catheters \[PICCs], tunnelled (cuffed or non\-cuffed) \[e.g. Hickman®; Becton Dickinson, US] and totally implanted \[e.g. PORT\-A\-CATH®; Smith Medical, US] will be eligible for inclusion.
Exclusion Criteria
- •\-End\-of\-life pathway/measures at recruitment
- •\-Pre\-existing coagulopathic condition not related to current diagnosis or treatment (e.g. Haemophilia A and B or other factor deficiency; Immune Thrombocytopenic Purpura (ITP); Von Willebrand’s disease)
- •\-Known allergy to heparin or T\-EDTA
- •; \-End\-of\-life pathway/measures at recruitment
- •\-Pre\-existing coagulopathic condition not related to current diagnosis or treatment (e.g. Haemophilia A and B or other factor deficiency; Immune Thrombocytopenic Purpura (ITP); Von Willebrand’s disease)
- •\-Known allergy to heparin or T\-EDTA
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
To evaluate the outcomes of paediatric cancer patients admitted to the intensive care unitCTRI/2018/01/011576ot applicable200
Completed
Not Applicable
Efficient healthcare for children with cancer using telemedicine in Schleswig-HolsteiC00-C97Malignant neoplasmsDRKS00021042Dekanat der Medizinischen Fakultät, Christian-Albrechts-Universität zu Kiel55
Completed
Not Applicable
Protection against chemotherapy induced damage in the digestive tract in childhood cancer patients.NL-OMON23956umico Research30
Recruiting
Not Applicable
ong-term follow-up care after cancer in childhood, adolescence and young adulthood in Schleswig-Holstein - New care offers on the topic of Cancer SurvivorshipFormer cancer patientsDRKS00027264Klinik für Kinder- und JugendmedizinPädiatrische Hämatologie und OnkologieUniversitätsklinikum Schleswig-Holstein100
Completed
Not Applicable
Pilot testing of a decision aid for nutrition support in paediatric oncology.Malnutrition in paediatric oncologyDiet and Nutrition - Other diet and nutrition disordersCancer - Any cancerACTRN12615001082594Behavioural Sciences Unit, Sydney Children's Hospital40